Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity

Clinical trial NCT00689208 · COMPLETED

Trial details

NCT number: NCT00689208
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Insulin Resistance

Start date: 2007-05-01
Primary completion: 2008-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.